Ubrelvy and Memory loss - a phase IV clinical study of FDA data

Summary:

Memory loss is found among people who take Ubrelvy, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ubrelvy and have Memory loss. It is created by eHealthMe based on reports of 1,606 people who have side effects when taking Ubrelvy from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

1,606 people reported to have side effects when taking Ubrelvy.
Among them, 18 people (1.12%) have Memory loss.

What is Ubrelvy?

Ubrelvy has active ingredients of ubrogepant. eHealthMe is studying from 1,635 Ubrelvy users for its effectiveness, alternative drugs and more.

What is Memory loss?

Memory loss is found to be associated with 4,071 drugs and 4,137 conditions by eHealthMe.

Number of Ubrelvy and Memory loss reports submitted per year:

Time on Ubrelvy when people have Memory loss *:

Gender of people who have Memory loss when taking Ubrelvy *:

female: 94.44 %
male: 5.56 %

Age of people who have Memory loss when taking Ubrelvy *:

Common drugs people take besides Ubrelvy *:

Common side effects people have besides Memory loss *:

Migraine (headache): 10 people, 55.56%
Feeling Abnormal: 4 people, 22.22%
Fatigue (feeling of tiredness): 3 people, 16.67%
Insomnia (sleeplessness): 3 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
Hair Loss: 2 people, 11.11%
Drug Ineffective: 2 people, 11.11%
Back Pain: 2 people, 11.11%
Chest Pain: 2 people, 11.11%
Neck Pain: 2 people, 11.11%

Common conditions people have *:

Migraine (headache): 14 people, 77.78%
High Blood Pressure: 2 people, 11.11%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 5.56%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.56%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.56%
Heavy Or Prolong Menstrual Bleeding: 1 person, 5.56%
Headache (pain in head): 1 person, 5.56%
Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ubrelvy and have Memory loss?

Check whether Memory loss is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Memory loss and when was it recovered:

Memory loss in Ubrelvy

Expand to all the drugs that have ingredients of ubrogepant:

Memory loss and drugs with ingredients of ubrogepant

Alternative drugs to, pros and cons of Ubrelvy:

Ubrelvy (1,635 reports)

Memory loss treatments and more:

Memory loss (214,027 reports)

COVID vaccines that are related to Memory loss:

Common drugs associated with Memory loss:

All the drugs that are associated with Memory loss:

Memory loss (4,071 drugs)

Common conditions associated with Memory loss:

All the conditions that are associated with Memory loss:

Memory loss (4,137 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ubrogepant (the active ingredients of Ubrelvy) and Ubrelvy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.